According to the National Health and Medical Research Council – NHMRC clinical trials across Australia are in the following categories:
– treatment trials to test new treatments, new medicines or combinations of medicines; or other new therapies such as surgery, the use of new medical devices or new approaches to surgery
– diagnostic or screening trials to evaluate tests or procedures to diagnose and detect diseases or conditions
– prevention trials to test new ways to prevent disease including medicines, vaccines, vitamins, or changes to diet, lifestyle or behaviour
Clinical trials in Australia need to be efficiently administrated and resourced with qualified healthcare professionals as well as suitable patients.
Shanny Dyer, CEO ARCS Australia talks about a recent summit where the CRO (Contract Research Organization) community was asked on the current state of clinical trials in Australia. Commentary from:
– Tanya Symons, Director at T Symons Associates
– Daniela Caiazza, Director Clinical Operations ANZ, Novotech CRO
– Adam Stoneley, Research Operations Manager, Icon Cancer Centre
– Gabrielle McKee, Chief Operating Officer, CNS Clinical Network
– Joe Taouk, Senior Director Research and Development, IQVIA
#AustralianHealthJournal #ClinicalTrials
You Might also like
-
Artificial Intelligence (AI) in clinical trials and clinical care
Australian Health Journal today continues a major episode release on Technology Aided Healthcare Delivery, with part 2 on Artificial Intelligence in trials and clinical care. Interviews were captured at AI, Machine Learning & Robotics in Health conference in October organised by Informa Australia.
-
SAHMRI Celebrates 10 Years of Research
SAHMRI represents an exciting and unique statewide concept, bringing together basic and translational research, South Australia’s three universities and the health system. SAHMRI works in collaboration with its partners to provide a clear focal point for health and medical research, including paving the way for new partnerships, innovative research projects and improved health outcomes.
Executive Director, Professor Maria Makrides spoke to Australian Health Journal about 3 achievements in the past 10 years that have had significant impact
International leadership breakthroughs in leukaemia research
Culturally appropriate Indigenous health research and clinical care
Omega 3 fatty acids as a preterm birth prevention -
Expansion of specialist training in regional & rural areas
Associate Professor Sanjay Jeganathan, Chair of the Council of Presidents of Medical Colleges (CPMC) states, ”Our rural and regional communities deserve the same access to specialist care as our cities. We’re seeing real results from our colleges’ commitment to rural training.”